一项针对1176例炎症性肠病患者过度使用类固醇的多中心审计
该多中心审计记录了英国未选择的炎症性肠病(IBD)门诊患者的类固醇使用情况,发现30%患者在既往12个月内接受过类固醇,14.9%存在类固醇依赖或过度使用,其中49.1%经盲法同行评审认为可避免,不适当类固醇过度使用的年发生率为7.1%。中重度溃疡性结肠炎(UC)和克罗恩病(CD)的比值比分别为4.59和4.60,IBD多学科团队和专病门诊与较低的不适当过度使用相关。
要点
- 1176例IBD门诊患者中30%在既往12个月接受过类固醇,14.9%存在类固醇依赖或过度使用。
- 类固醇依赖或过度使用在UC中占42.6%,高于CD的28.1%(P=0.027)。
- 不适当类固醇过度使用的年发生率为7.1%,其中49.1%的类固醇依赖或过度使用被认为可避免。
核心结论
- 英国IBD患者中类固醇依赖或过度使用发生于14.9%,其中7.1%为潜在可避免。
- 服务配置(IBD多学科团队、专病IBD门诊)显示出正面效果。
- 常规记录类固醇依赖或过度使用是可行的,应被视为质量指标。
研究设计与样本
- 多中心审计,记录未选择的英国IBD门诊患者的类固醇使用情况。
- 符合类固醇依赖或过度使用标准的病例接受盲法同行评审以判断类固醇处方是否可避免。
- 分析类固醇使用与患者/机构因素之间的关联,共纳入1176例患者。
主要发现
- 1176例患者中30%在既往12个月内接受过类固醇。
- 14.9%存在类固醇依赖或过度使用,中重度UC为42.6% vs CD为28.1%(P=0.027)。
- 类固醇依赖或过度使用在49.1%的病例中被认为可避免,不适当类固醇过度使用的年发生率为7.1%。
- 中重度相较于轻度/静止期疾病活动度的不适当类固醇过度使用比值比:UC为4.59(95%CI 1.53-20.64),CD为4.60(95%CI 2.21-12.00)。
- CD中,设有IBD多学科团队的中心不适当类固醇过度使用率较低(OR 0.62 [95%CI 0.46-0.91]);UC中专病IBD门诊对不适当类固醇过度使用有保护作用(OR 0.64,95%CI 0.21-0.94)。
关键数值与推荐
- 中重度相较于轻度/静止期疾病活动度的不适当类固醇过度使用比值比:UC为4.59(95%CI 1.53-20.64),CD为4.60(95%CI 2.21-12.00)。
- CD中,设有IBD多学科团队的中心的比值比为0.62(95%CI 0.46-0.91)。
- UC中,专病IBD门诊的比值比为0.64(95%CI 0.21-0.94)。
- 不适当类固醇过度使用的年发生率为7.1%。
临床怎么用
- 常规记录类固醇依赖或过度使用是可行的,应被视为质量指标。
- IBD多学科团队和专病IBD门诊与较低的不适当类固醇过度使用率相关。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Corticosteroids are central to inducing remission in inflammatory bowel disease (IBD) but are ineffective maintenance agents. AIM: To benchmark steroid usage in British outpatients and assess factors associated with excess exposure. METHODS: We recorded steroid use in unselected IBD outpatients. Cases meeting criteria for steroid dependency or excess were blind peer reviewed to determine whether steroid prescriptions were avoidable. Associations between steroid use and patient/institutional factors were analysed. RESULTS: Of 1176 patients, 30% received steroids in the prior 12 months. 14.9% had steroid dependency or excess, which was more common in moderate/severe ulcerative colitis (UC) than Crohn's disease (CD) (42.6% vs 28.1%; P = .027). Steroid dependency or excess was deemed avoidable in 49.1%. The annual incidence of inappropriate steroid excess was 7.1%. Mixed-effects logistic regression analysis revealed independent predictors of inappropriate steroid excess. The odds ratio (OR, 95%CI) for moderate/severe compared to mild/quiescent disease activity was 4.59 (1.53-20.64) for UC and 4.60 (2.21-12.00) for CD. In CD, lower rates of inappropriate steroid excess were found in centres with an IBD multi-disciplinary team (OR 0.62 [0.46-0.91]), whilst dedicated IBD clinics protected against inappropriate steroid excess in UC (OR 0.64, 95% CI 0.21-0.94). The total number of GI trainees was associated with rates of inappropriate steroid excess. CONCLUSIONS: Steroid dependency or excess occurred in 14.9% of British IBD patients (in 7.1% potentially avoidable). We demonstrated positive effects of service configurations (IBD multi-disciplinary team, dedicated IBD clinics). Routine recording of steroid dependency or excess is feasible and should be considered a quality metric.
引用
- Selinger CP, Parkes GC, Bassi A, et al. A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017. PMID: 28949018. doi:10.1111/apt.14334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。